融资融券数据显示，该股最新（7月30日）两融余额为5.96亿元，其中，融资余额为5.93亿元，融券余额 为226.72万元。近5日融资余额合计增加2741.25万元，增幅为4.84%，融券余额合计减少6.28万元，降幅 2.70%。（数据宝） 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交7.11亿元，其中，买入成交额为4.52亿 元，卖出成交额为2.59亿元，合计净买入1.93亿元。 深交所公开信息显示，当日该股因日收盘价涨幅达20.00%上榜，机构专用席位净卖出3286.50万元，深 股通净买入5693.86万元。 具体来看，今日上榜的营业部中，共有1家机构专用席位现身，即卖五，合计净卖出3286.50万元，深股 通为第一大买入营业部及第一大卖出营业部，买入金额为1.56亿元，卖出金额为9860.20万元，合计净买 入5693.86万元。 资金流向方面，今日该股主力资金净流入4.09亿元，其中，特大单净流入5.76亿元，大单资金净流出 1.67亿元。近5日主力资金净流入5.12亿元。 安科生物今日涨停，全天换手率27.06%，成交额38.34亿元，振幅17.80%。龙虎榜数据显示，机构净卖 出3 ...

Core Viewpoint - The assisted reproduction sector has shown a positive performance with a 1.72% increase, ranking third among concept sectors, driven by significant gains in several stocks [1][2]. Group 1: Sector Performance - As of July 31, the assisted reproduction concept increased by 1.72%, with 34 stocks rising, including Anke Bio and Gongtong Pharmaceutical, which both hit the 20% limit up [1]. - Notable gainers in the sector included Guangshengtang, Xinghao Pharmaceutical, and Hanyu Pharmaceutical, with increases of 18.04%, 8.03%, and 7.02% respectively [1]. - Conversely, stocks such as Jiabiyou, Changchun High-tech, and Zhejiang Medicine experienced declines of 3.70%, 3.02%, and 2.99% respectively [1]. Group 2: Capital Flow - The assisted reproduction sector saw a net inflow of 0.18 billion yuan, with 30 stocks receiving net inflows from major funds [2]. - Anke Bio led the sector with a net inflow of 4.09 billion yuan, followed by Zhongsheng Pharmaceutical and Hanshang Group with net inflows of 2.04 billion yuan and 1.44 billion yuan respectively [2]. - The top three stocks by net inflow ratio were Hanshang Group at 53.93%, Lideman at 35.62%, and Gongtong Pharmaceutical at 23.90% [3].

证券之星消息，7月31日生物制品板块较上一交易日上涨0.05%，安科生物领涨。当日上证指数报收于 3573.21，下跌1.18%。深证成指报收于11009.77，下跌1.73%。生物制品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 300009 | 安科生物 | 12.11 | 20.02% | 330.56万 | | 38.34亿 | | 688136 | 科兴制药 | 53.25 | 13.15% | 19.24万 | | 9.56亿 | | 688278 | 特宝生物 | 91.33 | 7.46% | 12.10万 | | 11.04亿 | | 300841 | 康华生物 | 77.47 | 5.76% | 11.37万 | | 8.67亿 | | 688293 | 奥浦迈 | 60.50 | 5.38% | 2.60万 | | 1.58亿 | | 301393 | 吴帆生物 | 61.69 | 4.86% | 7.17万 | | 4.37亿 | ...

7月31日，医疗美容概念上涨0.43%，今日主力资金流入2.44亿元，概念股24只上涨，46只下跌。 主力资金净流入居前的分别为安科生物（4.03亿元）、常山药业（2.5亿元）、汉商集团（1.1亿元）、 乐普医疗（6230.96万元）、振东制药（4677.6万元）。 序号代码名称最新价涨跌幅主力净流入主力净占比1300009安科生物12.1120.024.03亿元10.5%2300255常 山药业42.33.172.50亿元9.44%3600774汉商集团11.3310.01.10亿元40.97%4300003乐普医疗 15.560.846230.96万元5.49%5300158振东制药8.6216.644677.60万元2.15%6300238冠昊生物 17.41.163491.91万元8.34%7300753爱朋医疗31.397.283162.54万元5.27%8000725京东方Ａ4.04- 0.982808.99万元1.6%9000935四川双马19.550.572758.18万元9.8%10300244迪安诊断16.11.582710.14万元 4.4% 来源：金融界 ...

作者：金股通 截至7月31日收盘回顾，主力资金流入前20的股票分别为：三六零（11.33亿元）、易点天下（8.89亿 元）、用友网络（8.81亿元）、诺德股份（8.05亿元）、神州数码（7.60亿元）、天风证券（7.20亿 元）、长城军工（6.84亿元）、剑桥科技（6.81亿元）、拓维信息（6.16亿元）、寒武纪U（5.79亿 元）、利欧股份（5.47亿元）、XD工业富（5.43亿元）、浪潮信息（5.03亿元）、长盈精密（4.92亿 元）、川润股份（4.51亿元）、南兴股份（4.20亿元）、安科生物（4.03亿元）、农业银行（3.73亿 元）、昆仑万维（3.65亿元）、华胜天成（2.85亿元）。 本文源自：金融界 ...

Market Overview - On July 31, the A-share market closed with the Shanghai Composite Index at 3573.21, down 1.18%, and the Shenzhen Component Index at 11009.77, down 1.73% [1] Top Stocks Performance - Among the top 10 stocks in the ChiNext board by trading volume, 6 stocks saw gains with an average increase of 6.52%. Xinyi Technology (300502) led with a trading volume of 14.605 billion yuan [1] - In terms of net capital inflow, 4 out of the top 10 stocks experienced positive net inflow [1] Individual Stock Data - Xinyi Technology (300502): Latest price 189.21, down 0.60%, trading volume 14.605 billion yuan, net outflow -5.25 million yuan [2] - Zhongji Xuchuang (300308): Latest price 217.61, up 3.33%, trading volume 14.275 billion yuan, net outflow -2.39 million yuan [2] - Ningde Times (300750): Latest price 264.62, down 4.50%, trading volume 12.089 billion yuan, net outflow -16.63 million yuan [2] - Shenghong Technology (300476): Latest price 192.08, up 0.01%, trading volume 10.911 billion yuan, net inflow 10.196 million yuan [2] - Dongfang Caifu (300059): Latest price 23.23, down 2.44%, trading volume 10.438 billion yuan, net outflow -16.97 million yuan [2] - Tianhu Communication (300394): Latest price 105.63, up 3.87%, trading volume 7.019 billion yuan, net inflow 8.361 million yuan [2] - Changying Precision (300115): Latest price 22.72, up 8.86%, trading volume 4.784 billion yuan, net inflow 4.92 million yuan [2] - Zhizhen (300803): Latest price 88.77, down 3.50%, trading volume 3.893 billion yuan, net outflow -6.31 million yuan [2] - Anke Bio (300009): Latest price 12.11, up 20.02%, trading volume 3.834 billion yuan, net inflow 4.03 million yuan [2] - Kunlun Wanwei (300418): Latest price 35.90, up 3.01%, trading volume 3.699 billion yuan, net inflow 3.65 million yuan [2] ETF Performance - Food and Beverage ETF (Product Code: 515170): Recent five-day change -0.51%, PE ratio 20.31, latest shares 5.78 billion, increased by 45 million shares, net outflow -95.6 thousand yuan [5] - Gaming ETF (Product Code: 159869): Recent five-day change 2.52%, PE ratio 43.69, latest shares 7.04 billion, increased by 320 million shares, net inflow 1.5936 million yuan [5] - Semiconductor ETF (Product Code: 588170): Recent five-day change 2.16%, latest shares 370 million, increased by 2 million shares, net outflow -885.6 thousand yuan [5] - Cloud Computing 50 ETF (Product Code: 516630): Recent five-day change 3.33%, PE ratio 115.52, latest shares 440 million, increased by 3 million shares, net outflow -78.1 thousand yuan [6]

Market Overview - The A-share market experienced a decline with the Shanghai Composite Index falling by 1.18%, the Shenzhen Component Index down by 1.73%, and the ChiNext Index decreasing by 1.66% [1][2] - The total trading volume in the Shanghai and Shenzhen markets reached 1.94 trillion yuan, an increase of 91.7 billion yuan compared to the previous trading day, with over 4,200 stocks declining [1][2] Sector Performance - Sectors such as steel, energy metals, coal mining and processing, photovoltaic equipment, and film and television cinema saw declines, while the liquid cooling server sector showed strong performance [4] - The innovative drug concept continued to perform well, with several stocks including Nanxin Pharmaceutical, Anke Bio, and Aoxiang Pharmaceutical hitting the daily limit [4] - The liquid cooling server concept had multiple stocks, including Yingweike and Icewheel Environment, reaching the daily limit [4][5] Capital Flow - Major funds saw net inflows in sectors like banking, computers, and traditional Chinese medicine, while there were net outflows in mining, paper printing, and electronic components [6] - Specific stocks such as 360, Yidian Tianxia, and Yongyou Network received net inflows of 1.133 billion yuan, 889 million yuan, and 881 million yuan respectively [6] - Conversely, Baogang Group, Dongfang Fortune, and CATL faced net outflows of 1.868 billion yuan, 1.697 billion yuan, and 1.663 billion yuan respectively [6] Institutional Insights - Galaxy Securities suggests not to make bullish moves while the Shanghai Composite Index is below the 5-day moving average, indicating a high probability of filling the gap [6] - Everbright Securities notes that market sentiment remains active, with fluctuations being a normal adjustment within the trend [7] - CITIC Securities maintains that the index is expected to continue its upward trend despite short-term fluctuations [7]

金融界消息 截至2025年7月31日收盘，安科生物（300009）报收于12.11元，上涨20.02%，换手率 27.06%，成交量330.56万手，成交金额38.34亿元。 资金流向方面，今日主力资金净流入4.03亿元，占比成交额10.5%。其中，超大单净流入6.49亿元、占 成交额16.92%，大单净流出24587.28万元、占成交额6.41%，中单净流出流出41781.77万元、占成交额 10.9%，小单净流入1511.15万元、占成交额0.39%。 安科生物最新一期业绩显示，截至2025一季报，公司营业总收入6.29亿元、同比减少4.17%，归属净利 润2.09亿元，同比减少4.02%，扣非净利润1.97亿元，同比减少3.92%，流动比率3.071、速动比率 2.647、资产负债率16.52%。 天眼查商业履历信息显示，安徽安科生物工程(集团)股份有限公司，成立于2000年，位于合肥市，是一 家以从事研究和试验发展为主的企业。企业注册资本167255.3658万人民币，实缴资本2400万人民币。 公司法定代表人为宋礼华。 通过天眼查大数据分析，安徽安科生物工程(集团)股份有限公司共对外投资了24家企业 ...

Group 1 - The core viewpoint of the news is the strong performance of reproductive health-related stocks in both the Hong Kong and A-share markets, driven by new government policies aimed at enhancing reproductive health services [1] - The Beijing Municipal Government has issued a notice to improve the reproductive support policy system, which includes optimizing maternal and child healthcare resources and enhancing reproductive health technology [1] - Specific measures include the inclusion of suitable assisted reproductive technology projects in medical insurance coverage and the establishment of "birth-friendly" hospitals to improve the childbirth experience [1] Group 2 - Notable stock performances include: - Tonghua Pharmaceutical (共同药业) with a 19.99% increase and a market cap of 2.837 billion [2] - Lide Man (利德曼) rising by 19.93% with a market cap of 3.830 billion [2] - Anke Biotechnology (安科生物) increasing by 18.14% with a market cap of 19.9 billion [2] - Other companies such as Han Commercial Group (汉商集团) and Luoxin Pharmaceutical (罗欣药业) also saw significant gains, with both reaching the 10% limit up [1][2] - The overall trend indicates a positive market sentiment towards companies involved in reproductive health, with many stocks showing substantial year-to-date increases [2]

消息面上，近日，中共中央办公厅、国务院办公厅印发了《育儿补贴制度实施方案》。多部门有关负责 人7月30日在国新办举行的新闻发布会上介绍，2022年1月1日以后出生的符合条件的婴幼儿都可以领取 育儿补贴。按照工作计划，各地将在8月下旬陆续开放育儿补贴申领，8月31日前各地全面开放育儿补贴 的申领。据悉，中央财政将设立共同财政事权转移支付项目"育儿补贴补助资金"，今年初步安排预算 900亿元左右。 国家卫生健康委副主任郭燕红介绍，育儿补贴是新中国成立以来首次大范围、普惠式、直接性向群众发 放的民生保障现金补贴，是一项惠民利民的重大举措。育儿补贴不分城乡、民族、区域，也不分一孩、 二孩或者三孩，实现三孩生育政策下家庭支持的全面覆盖，确保符合条件的婴幼儿能够平等享受补贴的 待遇。 辅助生殖概念31日盘中走势活跃，截至发稿，共同药业（300966）、利德曼（300289）20%涨停，广生 堂（300436）涨超15%，安科生物（300009）涨近14%，汉商集团（600774）亦涨停。 万联证券指出，短期来看，育儿补贴的发放有助于直接刺激母婴相关的消费，建议关注婴童护理、乳制 品、玩具、童装等行业；长期来看，生育补贴和 ...